164 related articles for article (PubMed ID: 25201199)
1. Splice variants of MDM2 in oncogenesis.
Rosso M; Okoro DE; Bargonetti J
Subcell Biochem; 2014; 85():247-61. PubMed ID: 25201199
[TBL] [Abstract][Full Text] [Related]
2. Tumor promotion by Mdm2 splice variants unable to bind p53.
Fridman JS; Hernando E; Hemann MT; de Stanchina E; Cordon-Cardo C; Lowe SW
Cancer Res; 2003 Sep; 63(18):5703-6. PubMed ID: 14522887
[TBL] [Abstract][Full Text] [Related]
3. Endogenous human MDM2-C is highly expressed in human cancers and functions as a p53-independent growth activator.
Okoro DR; Arva N; Gao C; Polotskaia A; Puente C; Rosso M; Bargonetti J
PLoS One; 2013; 8(10):e77643. PubMed ID: 24147044
[TBL] [Abstract][Full Text] [Related]
4. Stress-induced alternative splice forms of MDM2 and MDMX modulate the p53-pathway in distinct ways.
Jacob AG; Singh RK; Comiskey DF; Rouhier MF; Mohammad F; Bebee TW; Chandler DS
PLoS One; 2014; 9(8):e104444. PubMed ID: 25105592
[TBL] [Abstract][Full Text] [Related]
5. Alternative and aberrant splicing of MDM2 mRNA in human cancer.
Bartel F; Taubert H; Harris LC
Cancer Cell; 2002 Jul; 2(1):9-15. PubMed ID: 12150820
[TBL] [Abstract][Full Text] [Related]
6. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
7. Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells.
Huun J; Gansmo LB; Mannsåker B; Iversen GT; Øvrebø JI; Lønning PE; Knappskog S
BMC Cell Biol; 2017 Apr; 18(1):17. PubMed ID: 28415963
[TBL] [Abstract][Full Text] [Related]
8. A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo.
Comiskey DF; Jacob AG; Sanford BL; Montes M; Goodwin AK; Steiner H; Matsa E; Tapia-Santos AS; Bebee TW; Grieves J; La Perle K; Boyaka P; Chandler DS
Oncogene; 2018 Jan; 37(1):95-106. PubMed ID: 28892044
[TBL] [Abstract][Full Text] [Related]
9. MDM2 splice variants predominantly localize to the nucleoplasm mediated by a COOH-terminal nuclear localization signal.
Schuster K; Fan L; Harris LC
Mol Cancer Res; 2007 Apr; 5(4):403-12. PubMed ID: 17426254
[TBL] [Abstract][Full Text] [Related]
10. Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms.
Matsumoto R; Tada M; Nozaki M; Zhang CL; Sawamura Y; Abe H
Cancer Res; 1998 Feb; 58(4):609-13. PubMed ID: 9485008
[TBL] [Abstract][Full Text] [Related]
11. Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4.
Fan C; Wang X
Cell Cycle; 2017 Apr; 16(7):660-664. PubMed ID: 28166445
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines.
Weng MW; Lai JC; Hsu CP; Yu KY; Chen CY; Lin TS; Lai WW; Lee H; Ko JL
Environ Mol Mutagen; 2005 Jul; 46(1):1-11. PubMed ID: 15714438
[TBL] [Abstract][Full Text] [Related]
13. Novel MDM2 splice variants identified from oral squamous cell carcinoma.
Sam KK; Gan CP; Yee PS; Chong CE; Lim KP; Karen-Ng LP; Chang WS; Nathan S; Rahman ZA; Ismail SM; Cheong SC
Oral Oncol; 2012 Nov; 48(11):1128-35. PubMed ID: 22705356
[TBL] [Abstract][Full Text] [Related]
14. MDM2-A, a common Mdm2 splice variant, causes perinatal lethality, reduced longevity and enhanced senescence.
Volk EL; Schuster K; Nemeth KM; Fan L; Harris LC
Dis Model Mech; 2009; 2(1-2):47-55. PubMed ID: 19132120
[TBL] [Abstract][Full Text] [Related]
15. [Any way you splice it: Mdm2 at the crossroads of tumor surveillance].
Lents NH
Ai Zheng; 2008 Sep; 27(9):993-7. PubMed ID: 18799043
[TBL] [Abstract][Full Text] [Related]
16. MDM2 and its splice variant messenger RNAs: expression in tumors and down-regulation using antisense oligonucleotides.
Bartel F; Harris LC; Würl P; Taubert H
Mol Cancer Res; 2004 Jan; 2(1):29-35. PubMed ID: 14757843
[TBL] [Abstract][Full Text] [Related]
17. Modulation of mdm2 pre-mRNA splicing by 9-aminoacridine-PNA (peptide nucleic acid) conjugates targeting intron-exon junctions.
Shiraishi T; Eysturskarth J; Nielsen PE
BMC Cancer; 2010 Jun; 10():342. PubMed ID: 20591158
[TBL] [Abstract][Full Text] [Related]
18. MDM2 splice variants and their therapeutic implications.
Harris LC
Curr Cancer Drug Targets; 2005 Feb; 5(1):21-6. PubMed ID: 15720186
[TBL] [Abstract][Full Text] [Related]
19. Novel mdm2 splice variants identified in pediatric rhabdomyosarcoma tumors and cell lines.
Bartel F; Taylor AC; Taubert H; Harris LC
Oncol Res; 2001; 12(11-12):451-7. PubMed ID: 11939408
[TBL] [Abstract][Full Text] [Related]
20. The MDM2-a splice variant of MDM2 alters transformation in vitro and the tumor spectrum in both Arf- and p53-null models of tumorigenesis.
Volk EL; Fan L; Schuster K; Rehg JE; Harris LC
Mol Cancer Res; 2009 Jun; 7(6):863-9. PubMed ID: 19491200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
